12/20/2024 | Press release | Archived content
Becker's Hospital Review
The Barbara Ann Karmanos Cancer Institute is the first in the world to prescribe the TheraBionic P1 device, an at-home treatment for adults with advanced liver cancer. The device was approved by the FDA in September 2023 for adult patients who have failed first- and second-line treatments.
Read the article here.
Click here to learn more about the TheraBonic P1 device.